Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 33.67B JPY in the quarter ending March 31, 2026, with 3.24% growth. This brings the company's revenue in the last twelve months to 166.80B, up 3.14% year-over-year. In the year 2025, Kobayashi Pharmaceutical had annual revenue of 165.74B with 0.09% growth.

• Revenue (ttm): 166.80B
• Revenue Growth: +3.14%
• P/S Ratio: 2.61
• Revenue / Employee: 44.71M
• Employees: 3,731
• Market Cap: 435.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	165.74B	142.00M	0.09%
Dec 31, 2024	165.60B	-7.86B	-4.53%
Dec 31, 2023	173.46B	7.20B	4.33%
Dec 31, 2022	166.26B	11.01B	7.09%
Dec 31, 2021	155.25B	4.74B	3.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error